BEOVU (brolucizumab-vfrm) Patient Assistance Program
Sight-saving injections shouldn’t hinge on affordability. The Novartis Patient Assistance Foundation provides Beovu free of charge to eligible patients — including Medicare patients — and we manage the entire enrollment for a flat $69.95 per month.
- Clear & Transparent Pricing — Applying To The Novartis Foundation Directly Is Always Free
- Paperwork, Documentation & Retina-Practice Coordination Handled For You
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part B Math Explained — Injections Bill Differently Than Pharmacy Drugs
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Beovu (Brolucizumab) Is An Anti-VEGF Injection For Wet Age-Related Macular Degeneration And Diabetic Macular Edema — Administered Into The Eye By A Retina Specialist, With Maintenance Intervals That Can Stretch To Every 8–12 Weeks, Fewer Visits Than Older Agents For Many Patients.
- Each Injection Runs About $2,125 In Drug Cost — And Because Beovu Is Physician-Administered, It Bills Through The Medical Benefit: Medicare Part B, Where Patients Without Supplemental Coverage Owe 20% Coinsurance (~$430 Per Injection) And The $2,100 Part D Cap Never Applies.
- The Novartis Patient Assistance Foundation Provides Beovu Free To Eligible Uninsured And Government-Insured Patients — Including Medicare — On 12-Month Enrollments With Annual Renewal.
- No Biosimilar Of Brolucizumab Exists, And Novartis Has Retired Beovu’s Standalone Copay Infrastructure — Making The Foundation, Supplemental Coverage, And Eye-Disease Charity Funds (Like HealthWell) The Real Levers.
What Is Beovu Prescription Assistance Program?
The Beovu Patient Assistance Program is run by the Novartis Patient Assistance Foundation (1-800-277-2254, Mon–Fri 8 AM–8 PM ET), which provides Beovu free of charge to eligible U.S. and Puerto Rico residents who are uninsured or have government insurance — including Medicare — and meet income guidelines, on 12-month enrollments renewed annually. Applying directly is always free. Beovu’s financial structure is what trips families up: as a physician-administered eye injection it bills under the medical benefit — Medicare Part B — so there’s no pharmacy copay, no Part D cap, and instead a 20% coinsurance on both the drug (~$430 per injection) and the injection procedure, recurring every 8–12 weeks indefinitely. A Medigap supplement or Medicare Advantage out-of-pocket maximum absorbs that for many; for those without, the foundation and charitable funds like HealthWell’s macular degeneration fund fill the gap. For a flat $69.95 per month, our Patient Advocates coordinate with your retina practice’s billing team, file the foundation paperwork, watch charity-fund openings, and keep every renewal current — because a missed anti-VEGF injection can cost vision, not just money.
Pharmacy Price Comparison
- Without assistance, Beovu costs roughly $1,800–$2,200 per injection. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$2,100/dose | Save ~$2,030/dose |
| CVS Pharmacy | ~$2,200/dose | Save ~$2,130/dose |
| Walmart | ~$1,900/dose | Save ~$1,830/dose |
| Costco | ~$1,850/dose | Save ~$1,780/dose |
Specialty Pharmacy | ~$1,950/dose | Save ~$1,880/dose |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Beovu Prescription Program?
The Novartis foundation is free to apply to and provides Beovu at no drug cost if approved. Our $69.95/month service covers full advocacy — the foundation filing, the Part B math, charity-fund watching, and coordination with your retina practice, for as long as injections continue.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
If approved by the manufacturer Patient Assistance Program, the patient may receive medication through the applicable program process
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Beovu:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
- Still $1,800–$2,200 per injection per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Beovu assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Beovu Prescription From Your Retina Specialist
- You Are Uninsured Or Government-Insured (Including Medicare) — Commercial Insurance Disqualifies Foundation Applicants Under The 2025 Rules
- Your Household Income Is Within The Foundation’s Guidelines For Your Household Size
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Beovu :
Beovu (brolucizumab) is an anti-VEGF biologic injected into the eye — it blocks the growth factor driving the leaky, abnormal blood vessels of wet age-related macular degeneration and diabetic macular edema.
How Beovu Works:
In wet AMD, vascular endothelial growth factor (VEGF) spurs fragile new vessels under the retina that leak fluid and blood, destroying central vision — fast. Brolucizumab is an engineered antibody fragment, the smallest in its class, allowing a high molar dose per injection; it binds VEGF and shuts the leak down. Its clinical niche is durability: many patients maintain on injections every 8–12 weeks rather than the 4-week cycles older agents demanded — fewer visits, fewer injections, and correspondingly lower annual coinsurance exposure.
Form and Use:
Administered by intravitreal injection in a retina specialist’s office — three monthly loading doses, then individualized maintenance intervals guided by imaging. Treatment is indefinite: wet AMD is controlled, not cured, and stopping usually means the leak returns. That indefiniteness is the financial planning point — this is a recurring medical-benefit cost measured in years, which is why supplements, the foundation, and charity funds matter more than any single bill.
Biosimilar Availability:
None — no brolucizumab biosimilar exists or is in near-term view. The anti-VEGF class does have alternatives with different economics (including biosimilars of ranibizumab and off-label bevacizumab, which is dramatically cheaper) — legitimate clinical conversations with your retina specialist, not substitutions we or a pharmacy can make. For Beovu itself, the foundation is the lever.
Warnings:
Beovu carries distinctive warnings for intraocular inflammation, including rare retinal vasculitis and retinal vascular occlusion that can cause severe vision loss — the reason for prompt reporting of any new floaters, pain, light sensitivity, or vision change after injection, and for the monitoring your retina practice schedules. Standard injection risks (endophthalmitis, retinal detachment, pressure spikes) apply. Report symptoms same-day, always — with this drug, speed protects sight.
FAQ (Frequently Asked Questions)
How Much Does Beovu Cost Without Insurance?
About $2,125 per injection in drug cost, plus procedure and imaging fees — recurring every 8–12 weeks indefinitely. Income-eligible uninsured and government-insured patients can receive the drug free through the Novartis Patient Assistance Foundation; our $69.95 monthly fee covers the filings and the Part B math around everything else.
Does Medicare Cover Beovu?
Yes — under Part B as a physician-administered drug, at 20% coinsurance (~$430 per injection) plus procedure cost-sharing after the deductible. The $2,100 Part D cap does not apply. A Medigap supplement or Medicare Advantage out-of-pocket maximum is what contains it — and income-eligible Medicare patients can route the drug cost through the foundation instead.
Is There A Copay Card For Beovu?
No active one — Novartis has retired Beovu’s standalone patient site and copay infrastructure. The foundation, supplemental coverage, and charity funds like HealthWell’s macular degeneration fund (800-675-8416) are the real routes; we track fund openings, which come and go.
Why Fewer Injections Than My Friend Gets With Another Drug?
Beovu’s design supports longer maintenance intervals — 8 to 12 weeks for many patients versus monthly for older agents. Interval decisions are imaging-driven and belong to your retina specialist; financially, fewer injections directly means less annual coinsurance.
What About Avastin — Isn’t It Much Cheaper?
Off-label bevacizumab costs a small fraction of branded anti-VEGF agents and is widely used first-line. Whether it, Beovu, or another agent fits your eyes is entirely clinical — but it’s a fair question to ask your specialist, and cost is a legitimate part of that conversation.
How Long Does Foundation Approval Last?
Twelve months, renewed annually. We track the renewal and re-file before it lapses — because injection schedules don’t pause for paperwork.
What If My Application Is Denied?
Denials are usually about documentation — income proof or insurance-status details under the foundation’s 2025 rules. Applications can be corrected and resubmitted, and charity funds run as the parallel path. We review the denial letter, fix what triggered it, and resubmit on your behalf.
Take Control of Your Medication Costs
Wet AMD treatment is a marathon of injections where the drug bill recurs like a subscription — and where the foundation, the right supplement, and well-timed charity funds turn it manageable. Coordinating that is our job. Check your eligibility today; the pre-qualification review is free, and if we can’t help you, you pay nothing.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.